Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes - Deborah Hinnen, 2015
Dosage and administration of SGLT2 inhibitors according to renal... | Download Table
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study | BMJ Open Diabetes
Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
Dapagliflozin- a novel SGLT2 inhibitor | PPT
Dapagliflozin - wikidoc
Pharmacokinetic parameters of DWP16001, dapagliflozin, and... | Download Scientific Diagram
Forxiga 10 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)
Forxiga 10 mg Tablet - Uses, Dosage, Side Effects, Price, Composition | Practo
Forxiga Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial | Drugs
Forxiga Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Dapagliflozin - wikidoc
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus - Komoroski - 2009 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Dose-response effect of dapagliflozin on day 7 24-hours urinary glucose... | Download Scientific Diagram
Dapagliflozin for the Treatment of Type 2 Diabetes | Semantic Scholar
Dapagliflozin - wikidoc
Forxiga 5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc)
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology
Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry
Dapagliflozin - wikidoc
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The
